{"id":"https://openalex.org/W3208046208","doi":null,"title":"INNATE IMMUNE DEFENCES AGAINST SARS COV-2 AND VIRAL COUNTERMEASURES","display_name":"INNATE IMMUNE DEFENCES AGAINST SARS COV-2 AND VIRAL COUNTERMEASURES","publication_year":2020,"publication_date":"2020-09-20","ids":{"openalex":"https://openalex.org/W3208046208","mag":"3208046208"},"language":"en","primary_location":{"id":"mag:3208046208","doi":null,"is_oa":true,"landing_page_url":"http://consortiumpublisher.org/index.php/jap/article/view/590","pdf_url":null,"source":{"id":"https://openalex.org/S2765003003","display_name":"Journal of Applied Pharmacy","issn_l":"1920-4159","issn":["1920-4159"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Applied Pharmacy","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"http://consortiumpublisher.org/index.php/jap/article/view/590","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075006919","display_name":"Frank Kirchhoff","orcid":"https://orcid.org/0000-0002-7052-2360","observed_orcids":["https://orcid.org/0000-0002-7052-2360"]},"institutions":[{"id":"https://openalex.org/I196349391","display_name":"Universit\u00e4t Ulm","ror":"https://ror.org/032000t02","country_code":"DE","type":"education","lineage":["https://openalex.org/I196349391"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Frank Kirchhoff","raw_affiliation_strings":["Institute of Molecular Virology, Ulm University Medical Cente"],"raw_orcid":"https://orcid.org/0000-0002-7052-2360","affiliations":[{"raw_affiliation_string":"Institute of Molecular Virology, Ulm University Medical Cente","institution_ids":["https://openalex.org/I196349391"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5075006919"],"corresponding_institution_ids":["https://openalex.org/I196349391"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.22980518,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":null,"first_page":"7","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.7041000127792358,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.7041000127792358,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.2865999937057495,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":1.0},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9549999833106995},{"id":"https://openalex.org/keywords/innate-immunity","display_name":"innate immunity","score":0.8220000267028809},{"id":"https://openalex.org/keywords/interferon","display_name":"interferon","score":0.8360000252723694},{"id":"https://openalex.org/keywords/nsp1","display_name":"Nsp1","score":0.8339999914169312},{"id":"https://openalex.org/keywords/mrna-translation-inhibition","display_name":"mRNA translation inhibition","score":0.6399999856948853},{"id":"https://openalex.org/keywords/cpg-dinucleotides","display_name":"CpG","score":0.8889999985694885},{"id":"https://openalex.org/keywords/viral-immune-evasion","display_name":"viral immune evasion","score":0.6840000152587891},{"id":"https://openalex.org/keywords/antiviral-factors","display_name":"antiviral factors","score":0.6899999976158142},{"id":"https://openalex.org/keywords/zoonotic-origin","display_name":"zoonotic origin","score":0.6150000095367432},{"id":"https://openalex.org/keywords/lung-cells","display_name":"lung cells","score":0.5009999871253967}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6939811706542969},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.65816330909729},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.6437569856643677},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.603215754032135},{"id":"https://openalex.org/C2777648638","wikidata":"https://www.wikidata.org/wiki/Q57751738","display_name":"Coronavirus","level":5,"score":0.5874268412590027},{"id":"https://openalex.org/C2776844884","wikidata":"https://www.wikidata.org/wiki/Q1134583","display_name":"Coronaviridae","level":5,"score":0.4684572219848633},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.4535532593727112},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.45240291953086853},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.43617311120033264},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.3149877190589905},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.21556240320205688},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1768243908882141},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.124335378408432},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3208046208","doi":null,"is_oa":true,"landing_page_url":"http://consortiumpublisher.org/index.php/jap/article/view/590","pdf_url":null,"source":{"id":"https://openalex.org/S2765003003","display_name":"Journal of Applied Pharmacy","issn_l":"1920-4159","issn":["1920-4159"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Applied Pharmacy","raw_type":null}],"best_oa_location":{"id":"mag:3208046208","doi":null,"is_oa":true,"landing_page_url":"http://consortiumpublisher.org/index.php/jap/article/view/590","pdf_url":null,"source":{"id":"https://openalex.org/S2765003003","display_name":"Journal of Applied Pharmacy","issn_l":"1920-4159","issn":["1920-4159"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Applied Pharmacy","raw_type":null},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3093413235","https://openalex.org/W3169460210","https://openalex.org/W3167245853","https://openalex.org/W4281656701","https://openalex.org/W3174967834","https://openalex.org/W3187376865","https://openalex.org/W4224021450","https://openalex.org/W4287838589","https://openalex.org/W4416451420","https://openalex.org/W3152730670"],"abstract_inverted_index":{"SARS-CoV-2,":[0,111],"the":[1,17,41,50,70,87,95,126],"causative":[2],"agent":[3],"of":[4,40,75,119,149],"Coronavirus":[5],"disease":[6],"2019":[7],"(COVID-19),":[8],"has":[9],"infected":[10],"more":[11],"than":[12],"22":[13],"million":[14],"people":[15],"around":[16],"globe.":[18],"Although":[19],"this":[20,113],"pandemic":[21,114],"pathogen":[22,115],"spreads":[23],"with":[24],"enormous":[25],"efficiency":[26],"it":[27],"seems":[28],"to":[29,33,46,55,80,125],"be":[30],"highly":[31],"sensitive":[32],"interferons.":[34],"Here,":[35],"I":[36,91,133],"will":[37,92,134],"discuss":[38],"some":[39],"mechanisms":[42],"allowing":[43],"SARS":[44,76,138],"CoV-2":[45,77,139],"prevent":[47],"control":[48],"by":[49],"innate":[51],"immune":[52,89],"response":[53],"and":[54,85],"escape":[56],"or":[57],"even":[58],"highjack":[59,142],"specific":[60,143],"cellular":[61,82],"antiviral":[144],"factors.":[63],"In":[64],"collaborative":[65],"studies,":[66],"we":[67],"found":[68],"that":[69,94,101,122,137],"non-structural":[71],"protein":[72,99],"1":[73],"(Nsp1)":[74],"targets":[78,103],"ribosomes":[79],"shutdown":[81],"mRNA":[83],"translation":[84],"consequently":[86],"response.":[90],"show":[93],"Zinc":[96],"finger":[97],"(ZAP)":[100],"specifically":[102],"CpG":[104,128],"dinucleotides":[105],"in":[106,130],"viral":[107],"RNA":[108],"sequences":[109],"restricts":[110],"although":[112],"emerged":[116],"from":[117],"zoonosis":[118],"a":[120],"coronavirus":[121],"was":[123],"preadapted":[124],"low":[127],"environment":[129],"humans.":[131],"Finally,":[132],"provide":[135],"evidence":[136],"may":[140],"actually":[141],"factor":[145],"for":[146],"efficient":[147],"infection":[148],"human":[150],"lung":[151],"cells.":[152]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2021-11-08T00:00:00"}